ARRAY BIOPHARMA INC
ARRAY BIOPHARMA INC (ARRY) is a publicly traded company in the Unknown sector. Across all available filings, 55 corporate insiders have executed 628 transactions totaling $3.4B, demonstrating a bearish sentiment with -$3.3B in net insider flow. The most recent transaction on Aug 1, 2025 involved a transaction of 1,390 shares valued at $8.4K.
ARRY Insider Activity Summary
Who Is Buying ARRY Stock?
No significant insider buying has been recorded for ARRY in the recent period.
Who Is Selling ARRY Stock?
No significant insider selling has been recorded for ARRY in the recent period.
Is ARRAY BIOPHARMA INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ARRY is bearish with an Insider Alignment Score of 1/100 and a net flow of -$3.3B. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ARRY Frequently Asked Questions
Understanding ARRY Insider Activity
Insider trading at ARRAY BIOPHARMA INC (ARRY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 55 insiders are actively trading ARRY stock, having executed 628 transactions in the past 90 days. The most active insider is Investment Parent, Llc Ati (Executive), who has made 2 transactions totaling $2.3B.
Related Tools
Track ARRAY BIOPHARMA INC Insider Activity
Get notified when executives and directors at ARRY file new Form 4 transactions